Sulfated colominic acid: An antiviral agent that inhibits the human immunodeficiency virus type 1 in vitro

Antiviral Research

Volumn 31, Issue 1-2, 1996, Pages 95-104

  Yang, Da Wei ^a,d   Ohta, Yasuhiro ^b   Yamaguchi, Shinya ^b   Tsukada, Yoji ^b   Haraguchi, Yuji ^a   Hoshino, Hiroo ^a   Amagai, Hatsuo ^c   Kobayashi, Isao ^c  

^a GUNMA UNIVERSITY   (Japan)

^b Marukin Shoyu Co Ltd   (Japan)

^c GUNMA UNIVERSITY HOSPITAL   (Japan)

^d Institute of Infectious Diseases   (China)

Author keywords

Acquired immunodeficiency syndrome; Enzyme linked immunosorbent assay; Human immunodeficiency virus type 1; Indirect immunofluorescence assay; Reverse transcriptase; Sulfated colominic acid

Indexed keywords

ANTIVIRUS AGENT; COLOMINIC ACID; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 0029971912     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(96)00957-6     Document Type: Article

References (41)

1. Abrams, D.I., Kuno, S., Wong, R., Jeffords, K., Nash, M., Molaghan, J.B., Gorter, R. and Ueno, R. (1989) Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann. Intern. Med. 110, 183-188.
2. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J. and Clercq, E.D. (1988) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 85, 6132-6136.
3. Baba, M., Clercq, E.D., Schols, D., Pauwels, R., Snoeck, R., Boeckel, C.V., Dedem, G.V., Kraaijeveld, N.. Hobbelen, P., Ottenhemijm, H. and Hollander, F.D. (1990) Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity. J. Infect. Dis. 161, 208-213.
4. Baba, M, Schols, D., Pauwels, R., Nakashima, H. and Clercq, E.D. (1990) Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J. AIDS. 3, 493-499.
5. Bagasra, O. and Lischner, H.W. (1988) Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. J. Infect. Dis. 158, 1084-1087.
6. Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W. and Montagnier, L. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
7. Batinic, D. and Robey, F.A. (1992) The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267, 6664-6671.
8. Callebaut, C., Krust, B., Jacotot, E. and Hovanessian, A.G. (1993) T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4-positive cells. Science 262, 2045-2050.
9. Dalgleish, A.G., Beverley, P.C.L., Clapham, P., Crawford, D.H., Greaves, M.F. and Weiss, R.A. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
10. Fischl, M.A., Richman, D.D., Grieco, M.H., Gottlieb, M.S., Volberding, P.A., Liskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Schooey, R.T., Jackson, G.G., Durack, D.T., Phil. D., King, D. and the AZT collaborative working group (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N. Engl. J. Med. 317, 185-191.
11. Fitzgibbon, J.E., Howell, R.M., Haberzettl, C.A., Sperber, S.J., Gocke, D.J. and Dubin, DT. (1992) Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′,3′-dideoxycytidine. Antimicrob. Agents Chemother. 36, 153-157.
12. Gallo, R.C, Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P. and Markham, P.D. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
13. Handa, A., Hoshino, H., Nakajima, K., Adachi, M., Ikeda, K., Achiwa, K., Itoh, T. and Suzuki, Y. (1991) Inhibition of infection with human immunodeficiency virus type 1 by sulfated gangliosides. Biochem. Biophys. Res. Commun. 175, 1-9.
14. Harada, S., Koyanagi, Y. and Yamamoto. N. (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566.
15. Hartman, N.R., Johns, D.J. and Mitsuya, H. (1990) Pharmacokinetic analysis of dextran sulfate in rats as pertains to its clinical usefulness for therapy of HIV infection. AIDS Res. Hum. Retroviruses 6, 805-812.
16. Hoshino, H., Tanaka, H., Miwa, M. and Okada, H. (1984) Human T-cell leukaemia virus is not lysed by human serum. Nature 310, 324-325.
17. Ito, M., Baba, M., Sato, A., Pauwels, R., Clercq, E.D. and Shigeta, S. (1987) Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res. 7, 361-367.
18. Kawaguchi, T., Nakakuma, H., Kagimoto, T., Shirono, K., Horikawa, K., Hidaka, M., Iwamori, M., Nagai, Y. and Takatsuki, K. (1989) Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytes. Biochem. Biophys. Res. Commun. 158, 1050-1059.
19. Kikukawa, R., Koyanagi, Y., Harada, S., Kobayashi, N., Hatanaka, M. and Yamamoto, N. (1986) Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J. Virol. 57, 1159-1162.
20. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.C. and Montagnier, L. (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
21. Lang, W., Osmond, D., Page-Bodkin, K., Moss, A. and Winkelstein Jr., W. (1993) Population-based estimates of antiretroviral therapy and anti-pneumocystis prophylaxis in San Francisco: 1991. J. Acquir. Immune. Defic. Syndr. 6, 191-195.
22. Larder, B.A. and Kemp, S.D. (1989) Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246, 1155-1158.
23. Levy, J.A., Hoffman, A.D., Kramer, S.M., Landis, J.A., Shimabukuro, J.M. and Oshiro, L.S. (1984) Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS Science, 225, 840-842.
24. Lorentsen, K.J., Hendrix, C.W., Collins, J.M., Kornhauser, D.M., Petty, B.G., Klecker, R.W., Flexner, C., Eckel, R.H. and Lietman, P.S. (1989) Dextran sulfate is poorly absorbed after oral administration. Ann. Intern. Med. 111, 561-566.
25. McGuire, E.J. and Binkley, S.B. (1964) The structure and chemistry of colominic acid. Biochemistry 3, 247-251.
26. Mitsuya, H. and Broder, S. (1986) Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 83, 1911-1915.
27. Mitsuya, H., Weinhold, K.J., Furman, P.A., St. Clair, M.H., Lehrman, S.N., Gallo, R.C., Bolognesi, D., Barry, D.W. and Broder, S. (1985) 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA 82, 7096-7100.
28. Mitsuya, H., Looney, D.J., Kuno, S., Ueno, R., Wong-Staal, F. and Broder, S. (1988) Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4-positive cells. Science 240, 646-649.
29. Nakashima, H., Kido, Y., Kobayashi, N., Motoki, Y., Neushul, M. and Yamamoto, N. (1987) Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae. Antimicrob. Agents Chemother. 31, 1524-1528.
30. Nakashima, H., Tanabe, A., Tochikura, T.S. and Yamamoto, N. (1988) Rapid screening method with a cell multisizer for inhibitors of human immunodeficiency virus-induced cell fusion in vitro. J. Clin. Microbiol. 26, 1229-1232.
31. Okada, T., Patterson, B.K. and Gurney, M.E. (1995) Inhibition of anti-V3 domain antibody binding to human immunodeficiency virus type-1-infected cells by sulfated polysaccharides. Biochem. Biophys. Res. Commun. 209, 850-858.
32. Poiesz, B.J., Ruscetti, F.W., Gardar, A.F., Bunn, P.A., Minna, J.D. and Gallo, R.C. (1980) Detection and isolation of type C retrovirus particles from fresh and culture lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77, 7415-7419.
33. Popovic, M., Sarngadharan, M.G., Read, E. and Gallo, R.C. (1984) Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500.
34. Richman, D.D., Fischl, M.A., Grieco, M.H., Gottlieb, M.S., Volberding, P.A., Liskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Hirsch, M.S., Jackson, G.G., Durack, D.T., Phil, D., Nusinotf-Lehrman, S. and the AZT collaborative working group (1987) The toxicity of Azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex, a double blind, placebo controlled trial. N. Engl. J. Med. 317, 192-197.
35. Salahuddin, S.Z., Markham, P.D., Wong-Staal, F., Franchini, G., Kalyanaraman, V.S. and Gallo, R.C. (1983) Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129, 51-64.
36. St. Clair, M.H., Martin, J.L., Tudor-Williams, G., Bach, M.C., Vavro, C.L., King, D.M., Kellam, P., Kemp, S.D. and Larder, B.A. (1991) Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557-1559.
37. Takeuchi, Y., Inagaki, M., Kobayashi, N. and Hoshino, H. (1987) Isolation of human immunodeficiency virus from a Japanese hemophilia B patients with AIDS. Jpn. J. Cancer Res. (Gann) 78, 11-15.
38. Ueno, R. and Kuno, S. (1987) Dextran sulfate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet June 13, 1379.
39. Yarchoan, R., Klecker, R.W., Weinhold, K.J., Markham, P.D., Lyerly, H.K., Durack, D.T., Gelmann, R., Lehrman, S.N., Blum, R.M., Barry, D.W., Shearer, G.M., Fischil, M.A., Mitsuya, H., Gallo, R.C., Collins, J.M., Bolognesi, D.P., Myers, C.E. and Broder, S. (1986) Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/ LAV replication, to patients with AIDS or AIDS-related complex. Lancet 8481, 575-580.
40. Yarchoan, R., Perno, C-F., Thomas, R.V., Klecker, R.W., Allain, J.P., Wills, J., McAtee, N., Fischl, M.A., Dubinski, R., Mcneely, M.C., Mitsuya, H., Pluda, J.M., Lawley, T.J., Leuther, M., Safai, B., Collins, J.M., Myers, C.E. and Broder, S. (1988) Phase 1 studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet 8577, 76-81.
41. Yarchoan, R., Mitsuya, H., Thomas, R.V., Pluda, J.M., Hartman, N.R., Perno, C-F., Marczyk, K.S., Allain, J.-P., Johns, D.G. and Broder, S. (1989) In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 28, 412-415.